<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01446380</url>
  </required_header>
  <id_info>
    <org_study_id>AC 2008 871</org_study_id>
    <nct_id>NCT01446380</nct_id>
  </id_info>
  <brief_title>Phenotypic Expressions in a French Pseudoxanthoma-Elasticum Cohort</brief_title>
  <official_title>Phenotypic Expressions in a French Pseudoxanthoma-Elasticum Cohort</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Angers</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Angers</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The cohort is intended to study the phenotypic expressions of the pseudoxanthoma elasticum
      (PXE) disease in various tissues (eye, skin, arteries, etc).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This national french cohort is intended to improve our knowledge on the PXE disease. The
      study of phenotypic expression of the diseases is focused on cutaneous, opthalmologic and
      vascular tissues. All investigations are included in a yearly follow-up for these patients
      and collected in a database.

      Plasma are also collected for all patients and stored in our clinical research biological
      center in Angers, including genetic (DNA) material extracted from diagnostic skin biopsy.
      French Ministry of Teaching and Research Authorisation number for the PXE collection is AC
      2008 871. Declarative number is DC 2008 870.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2008</start_date>
  <completion_date type="Anticipated">January 2021</completion_date>
  <primary_completion_date type="Anticipated">January 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">350</enrollment>
  <condition>Pseudoxanthoma Elasticum</condition>
  <arm_group>
    <arm_group_label>Pseudoxanthoma elasticum</arm_group_label>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Sera,Plasma,DNA,skin biopsy
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients diagnosed for a PXE disease from any part of France and requesting a follow-up and
        clinical management of there disease (opthalmic and vascular complications mainly).
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with PXE disease

          -  Informed consent obtained

          -  Patient affiliated to Health care system (french social security)

        Exclusion Criteria:

          -  No informed consent

          -  No affiliation to a Health care system
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ludovic MARTIN, MD PhD</last_name>
    <role>Study Director</role>
    <affiliation>UH Angers</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ludovic MARTIN, MD PhD</last_name>
    <phone>33(2)41-35-34-19</phone>
    <email>LuMartin@chu-angers.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Georges LEFTHERIOTIS, MD-PHD</last_name>
    <phone>33(2)41-35-44-56</phone>
    <email>GeLeftheriotis@chu-angers.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital of Angers</name>
      <address>
        <city>Angers</city>
        <state>Pays de Loire</state>
        <zip>49933</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ludovic MARTIN, MD-PhD</last_name>
      <phone>33(0)2-41-35-34-19</phone>
      <email>LuMartin@chu-angers.fr</email>
    </contact>
    <contact_backup>
      <last_name>Georges LEFTHERIOTIS, MD-PhD</last_name>
      <phone>33(0)2-41-35-44-56</phone>
      <email>GeLeftheriotis@chu-angers.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Georges LEFTHERIOTIS, MD-PHD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pierre ABRAHAM, MD-PHD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fabrice PRUNIER, MD-PHD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean Marc EBRAN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Naouri M, Boisseau C, Bonicel P, Daudon P, Bonneau D, Chassaing N, Martin L. Manifestations of pseudoxanthoma elasticum in childhood. Br J Dermatol. 2009 Sep;161(3):635-9. doi: 10.1111/j.1365-2133.2009.09298.x. Epub 2009 Jun 9.</citation>
    <PMID>19519828</PMID>
  </reference>
  <reference>
    <citation>Martin L, Ma√Ætre F, Bonicel P, Daudon P, Verny C, Bonneau D, Le Saux O, Chassaing N. Heterozygosity for a single mutation in the ABCC6 gene may closely mimic PXE: consequences of this phenotype overlap for the definition of PXE. Arch Dermatol. 2008 Mar;144(3):301-6. doi: 10.1001/archderm.144.3.301.</citation>
    <PMID>18347285</PMID>
  </reference>
  <verification_date>October 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 3, 2010</study_first_submitted>
  <study_first_submitted_qc>October 3, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 5, 2011</study_first_posted>
  <last_update_submitted>October 3, 2011</last_update_submitted>
  <last_update_submitted_qc>October 3, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 5, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pseudoxanthoma Elasticum</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

